Johnson Pharmacare Ltd — Board Meeting, 23-07-2025: Board Meeting

Johnson Pharmacare's board has approved the financial results for the quarter ended June 30, 2025. The company reported a net loss of Rs 0.05 Cr for the quarter, a significant improvement from the Rs 0.51 Cr net loss in the prior year's comparable quarter. Notably, operational revenue for the period remained at zero. This outcome continues to reflect a business in its early stages or facing challenges, as the company sustains losses. Basic and diluted Earnings Per Share stood at (Rs 0.00) for the quarter, indicating no profit generation for shareholders.